1-10 of 10
Gary L. Rosner
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Shortened-Duration Tacrolimus after Nonmyeloablative HLA-Haploidentical (NMA haplo) BMT with High-Dose Posttransplantation Cyclophosphamide (PTCy) Facilitates Strategies for Relapse Reduction

Yvette L. Kasamon, Ephraim J. Fuchs, MD, Marianna Zahurak, Gary L. Rosner, Heather J. Symons, Javier Bolaños-Meade, Richard J. Jones
Journal: Blood
Blood (2016) 128 (22): 831.
https://doi.org/10.1182/blood.V128.22.831.831
Published: 2016
Journal Articles

Randomized Phase II Trial of Timed Sequential Cytosine Arabinoside with and without the CHK1 Inhibitor MK-8876 in Adults with Relapsed and Refractory Acute Myelogenous Leukemia

Jonathan Allen Webster, MD, Raoul Tibes, MD PhD, Amanda Blackford, ScM, Lawrence Morris, MD, Mrinal M Patnaik, MBBS, Lihua Wang, PhD, Melanie Rebechi, BS, Jacqueline Greer, RN, Mark R Litzow, MD, Larry Karnitz, PhD, Gary L. Rosner, Austin Doyle, MD, Scott H. Kaufmann, MD PhD, Judith E Karp, MD, B. Douglas Smith, MD
Journal: Blood
Blood (2015) 126 (23): 2563.
https://doi.org/10.1182/blood.V126.23.2563.2563
Published: 2015
Journal Articles

Nonmyeloablative (NMA), HLA-Mismatched Unrelated Donor (mMUD) BMT with High-Dose Posttransplantation Cyclophosphamide (PTCy) Has Outcomes Similar to Matched BMT

Yvette L. Kasamon, Ephraim J. Fuchs, Javier Bolaños-Meade, Mary S. Leffell, Marianna Zahurak, Gary L. Rosner, Jonathan D. Powell, Richard F. Ambinder, Richard J. Jones, Leo Luznik
Journal: Blood
Blood (2015) 126 (23): 2002.
https://doi.org/10.1182/blood.V126.23.2002.2002
Published: 2015
Journal Articles

Risk-stratified outcomes of nonmyeloablative HLA-haploidentical BMT with high-dose posttransplantation cyclophosphamide

Clinical Trials & Observations
Shannon R. McCurdy, Jennifer A. Kanakry, Margaret M. Showel, Hua-Ling Tsai, Javier Bolaños-Meade, Gary L. Rosner, Christopher G. Kanakry, Karlo Perica, Heather J. Symons, Robert A. Brodsky, Douglas E. Gladstone, Carol Ann Huff, Keith W. Pratz, Gabrielle T. Prince, Amy E. Dezern, Ivana Gojo, William H. Matsui, Ivan Borrello, Michael A. McDevitt, Lode J. Swinnen, B. Douglas Smith, Mark J. Levis, Richard F. Ambinder, Leo Luznik, Richard J. Jones, Ephraim J. Fuchs, Yvette L. Kasamon
Journal: Blood
Blood (2015) 125 (19): 3024–3031.
https://doi.org/10.1182/blood-2015-01-623991
Published: 2015
Includes: Supplemental data
Journal Articles

Single-agent GVHD prophylaxis with posttransplantation cyclophosphamide after myeloablative, HLA-matched BMT for AML, ALL, and MDS

Christopher G. Kanakry, Hua-Ling Tsai, Javier Bolaños-Meade, B. Douglas Smith, Ivana Gojo, Jennifer A. Kanakry, Yvette L. Kasamon, Douglas E. Gladstone, William Matsui, Ivan Borrello, Carol Ann Huff, Lode J. Swinnen, Jonathan D. Powell, Keith W. Pratz, Amy E. DeZern, Margaret M. Showel, Michael A. McDevitt, Robert A. Brodsky, Mark J. Levis, Richard F. Ambinder, Ephraim J. Fuchs, Gary L. Rosner, Richard J. Jones, Leo Luznik
Journal: Blood
Blood (2014) 124 (25): 3817–3827.
https://doi.org/10.1182/blood-2014-07-587477
Published: 2014
Includes: Supplemental data
Journal Articles

Graft-Versus-Host Disease (GVHD) and Survival Outcomes after HLA-Haploidentical (Haplo) Bone Marrow Transplant (BMT) Compare Favorably with Matched Related Donor (MRD), and Matched Unrelated Donor (MUD) BMT Utilizing High-Dose Posttransplantation Cyclophosphamide (PTCy)

Shannon R. McCurdy, Christopher G. Kanakry, Yvette L. Kasamon, MD, Javier Bolanos Meade, MD, Hua-Ling Tsai, Margaret M. Showel, Jennifer A. Kanakry, Heather J. Symons, MD MHS, Gary L. Rosner, Sc.D, Ephraim J. Fuchs, Richard J. Jones, Leo Luznik, MD
Journal: Blood
Blood (2014) 124 (21): 730.
https://doi.org/10.1182/blood.V124.21.730.730
Published: 2014
Journal Articles

Residual DNA methylation at remission is prognostic in adult Philadelphia chromosome–negative acute lymphocytic leukemia

Clinical Trials & Observations
Hui Yang, Tapan Kadia, Lianchun Xiao, Carlos E. Bueso-Ramos, Koyu Hoshino, Deborah Ann Thomas, Susan O'Brien, Elias Jabbour, Sherry Pierce, Gary L. Rosner, Hagop M. Kantarjian, Guillermo Garcia-Manero
Journal: Blood
Blood (2009) 113 (9): 1892–1898.
https://doi.org/10.1182/blood-2008-02-141002
Published: 2009
Journal Articles

Pharmacogenetics of minimal residual disease response in children with B-precursor acute lymphoblastic leukemia: a report from the Children's Oncology Group

Clinical Trials & Observations
Stella M. Davies, Michael J. Borowitz, Gary L. Rosner, Kristin Ritz, Meenakshi Devidas, Naomi Winick, Paul L. Martin, Paul Bowman, James Elliott, Cheryl Willman, Soma Das, Edwin H. Cook, Mary V. Relling
Journal: Blood
Blood (2008) 111 (6): 2984–2990.
https://doi.org/10.1182/blood-2007-09-114082
Published: 2008
Includes: Supplemental data
Journal Articles

Ancestry and pharmacogenetics of antileukemic drug toxicity

Clinical Trials & Observations
Shinji Kishi, Cheng Cheng, Deborah French, Deqing Pei, Soma Das, Edwin H. Cook, Nobuko Hijiya, Carmelo Rizzari, Gary L. Rosner, Tony Frudakis, Ching-Hon Pui, William E. Evans, Mary V. Relling
Journal: Blood
Blood (2007) 109 (10): 4151–4157.
https://doi.org/10.1182/blood-2006-10-054528
Published: 2007
Includes: Supplemental data
Journal Articles

Effects of prednisone and genetic polymorphisms on etoposide disposition in children with acute lymphoblastic leukemia

Clinical Trials & Observations
Shinji Kishi, Wenjian Yang, Benoit Boureau, Stanislas Morand, Soma Das, Peixian Chen, Edwin H. Cook, Gary L. Rosner, Erin Schuetz, Ching-Hon Pui, Mary V. Relling
Journal: Blood
Blood (2004) 103 (1): 67–72.
https://doi.org/10.1182/blood-2003-06-2105
Published: 2004
Includes: Supplemental data